Experimental autoimmune encephalomyelitis (EAE) is an autoimmune inflammatory and demyelinating disease of the central nervous system (CNS) inducible in rodents and other mammalian species by active or adoptive sensitization to CNS constituents (Paterson, 1980; Lassmann, 1983) . It has been used extensively as an animal model of the human demyelinating condition multiple sclerosis, the pathogenesis of which is probably immunemediated (Lassmann, 1983; Alvord et al. 1984; Bernard & Kerlere de Rorbo, 1992; ffrenchConstant, 1994) . Following immunization of rodents with neuroantigen(s) in Freund's complete adjuvant, there is proliferation of CNS-reactive T-lymphocytes in regional lymphoid tissues, migration of blood-borne CD4+ T-lymphocytes across the blood-brain barrier, and recruitment of inflammatory mononuclear leucocytes into the CNS (Paterson, 1980; Fallis et al. 1987; Hayosh et al. 1989; Cross et al. 1991) . Meade et al. (1978) and Hughes et al. (1980) found that linoleic acid could partially suppress guinea-pig EAE when given continuously or 7 d post-inoculation. Furthermore, Mertin & Stackpoole (1978 and Mertin (1981) found that a high-linoleic-acid and low-y-linolenic-acid-rich oil given 7 d post-inoculation partially suppressed EAE in the rat. Mertin & Stackpoole (1978 found that this partial suppression in the rat could be abolished by treatment with indomethacin and that splenectomy could abrogate the suppressive effect. The conclusions mononuclear infiltrated sites following the protocol: -, no lesions; + , up to four or five lesions on the entire section; + +, a few lesions in each of several different low-power fields ; + + + , lesions in many different fields; + + + + , many lesions in all or almost all fields.
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Animals and treatments for ex vivo investigations Healthy female Lewis rats (8-9 weeks old) were used in these studies. Spleens were aseptically removed from control untreated animals and animals given oral safflower-seed oil at 1000 mg linoleic acid/kg body weight or fungal oil at 500 mg ylinolenic acid/kg body weight daily for 4 or 12 d. A 100-150 mg sample of spleen tissue was excised and immediately frozen at -20" for subsequent fatty acid analysis.
Lymphocyte proliferation msay
Spleens from untreated and 4 or 12 d treated animals were teased apart in RPMI 1640 in petri dishes to release cells. The resulting cell suspension was centrifuged at 250 g and the pellet washed in RPMI 1640. Erythrocytes were lysed with Tris-NH,Cl and the cells resuspended in RPMI plus 5 % (v/v) fetal calf serum (FCS). Cells were counted using an improved Neubauer haemocytometer (BDH, Lutterworth, Leks.) and found to be > 95 % viable as determined by phase-contrast microscopy. Cells and Con A (Sigma) (100 pl each)
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were transferred into flat-bottomed 96 multiwell plates (Nunc, Kamstrup, Denmark) to give a final cell density of 5 x lo6 cells/ml and Con-A concentrations of 0, 1,2, or 4 pglml. Antibiotics were also included as 125 mg/ml ampicillin and 125 mg/ml cloxacillin. Plates were left undisturbed for 48 h at which time 37 Bq/well of [3H]thymidine (Amersham International Ltd., Bucks.) was added and the cultures left for a further 8 h. Cells were collected by cell harvester (Skatron, Norway) and counted for 1 min/sample on a liquid scintillation analyser (Tri-Carb 2000CA Packard, Pangbourne, Berks.) . Results are expressed as a stimulation index which is the mean counts per minute (CPM) of Con Astimulated cultures divided by the mean CPM of cultures without Con A.
Spleen lymphocyte sub-set analysis Splenic lymphocytes, prepared as above, were incubated with the following primary mouse monoclonal antibodies to rat lymphocytes obtained from Serotec (Oxford, Oxon.) : MRC OX-8 (suppressor/cytotoxic T-cells, CD8) and W3/25 (helper T-cells, CD4). Primary antibodies were diluted in phosphate-buffered saline (PBS) at 1 : 100. The secondary antibody ST-AR 9 (Serotec), a F(ab), rabbit anti-mouse immunoglobulin G (IgG) fluorescein isothiocyanate conjugate (FITC), was diluted 1 : 50 with PBS. Splenic cells prepared from control and treated animals in RPMI 1640 plus 5 % (v/v) FCS, at 10 x lo6 cells/ml, were washed twice and resuspended at the same density with PBS. Portions of 100 pl (lo6 cells) were transferred to cylindrical round-bottomed plastic centrifuge tubes, spun down in multi-tube carriers at 1000 rev./min on a IEC centra-7 centrifuge (International Equipment Company, Dunstable, Beds.), resuspended in 0.5 ml PBS and centrifuged for 5 min, and the supernatant fractions removed using sterile plastic Pasteur pipettes. To the pelleted cells 50 pl primary antibody was added (50 pl/106 cells), the cells were resuspended and incubated for 15 min at room temperature. The antibodies ST-AR 9 (anti-mouse IgG) and W6/32 (anti-HLA (ABC) Class I) were also used as negative controls at the primary antibody stage. The cells were washed in 1 ml PBS, centrifuged, and to the cell pellet the secondary antibody (FITC) was added at 50p1, incubated at room temperature for 15 min and washed and centrifuged twice with 1 ml PBS. The percentage of positive cells was obtained from analysis of 2 x lo3 cells using a FACScan flow cytometer (Becton Dickinson, Oxford, Oxon.).
Spleen lipid extraction and separation
Lipids were extracted from spleen tissue by the method of Folch et al. (1957) . Individual phosphoglycerides from the total lipid extract were separated by TLC on precoated silica gel 60A (Whatman, Maidstone, Kent) plates (200 x 200 mm) and identified by co-migration with bovine sources of L-u-phosphatidylcholine and L-u-phosphatidylethanolamine (Sigma). Plates were developed in chloroforn-methanol-water (65 : 24 : 4, by vol.) containing 2,6-di-t-butyl-4-methylphenol (0.1 g/l) and the resulting phosphoglycerides visualized under a U.V. lamp (Camag TL-900, Camlab Ltd., Cambridge, Cambs.) after spraying the dried plate with 2,7-dichlorofluorescein (1 ml/l in methanol). Fatty acid separation and identification were as described previously (Harbige et al. 1990 ). Briefly, they involved transmethylation of phosphoglyceride fatty acids at 70" followed by petroleum spirit extraction, evaporation to dryness and injection on to a GLC column. The chromatograph utilized was a Pye Unicam model 204 equipped with dual flame-ionization detectors, the column was a 25 m x 0.53 nm x 2 pm polyethylene glycol (Carbowax 20M immob) capillary column. Fatty acid methyl esters were identified by equivalent chain length (ECL) values (Ackman, 1969) and comparison with authentic standards (Sigma) and quantified as percentage total peak areas for fatty acid methyl esters between palmitic (16 : 0) and docosahexaenoic (22 : 6n-3) acids.
Statistical analysis
Differences in the incidence of clinical (score 1 and above) and histological disease between control EAE and treatments were assessed using x2 analysis. Differences in the clinical severity between treatment groups were compared using the Wilcoxon sum of ranks test. Differences between the effect of treatment on mitogen stimulation were analysed using Student's unpaired t test. Fatty acid differences were assessed using one-way ANOVA and when significant, differences between the means were evaluated by Student's unpaired t test (Clarke, 1982) .
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RESULTS
Incidence of clinical experimental autoimmune encephalomyelitis in saflower-seed-and
fungal-oil-treated Lewis rats The incidence of EAE in rats inoculated with CNS homogenate, and treated 7 d later with safflower-seed oil at 500 mg linoleic acid/kg body weight or fungal oil at 500 mg y-linolenic acid/kg body weight are shown in Figs 1 and 2 respectively. There were no significant differences in the clinical incidence of EAE between safflower-seed-oil-treated and untreated EAE rats (Fig. 1) . Fungal-oil treatment markedly reduced the incidence of EAE compared with control EAE animals and gave full protection against the clinical disease ( Fig. 2 ).
Dose-response efects of saflower-seed oil on clinical experimental autoimmune encephalomyelitis Dose-response incidence for EAE to linoleic-acid-rich safflower-seed oil (mg/kg body weight) is shown in Table 3 . These were not significantly different for untreated EAE and animals treated with 500 and 750 mg linoleic acid/kg body weight. Differences in incidence between the untreated EAE and the 1OOOmglinoleic acid/kg group at day 21 were, however, significantly lower (P < 0.005). In contrast, the dose-response curves for the effect of safflower-seed oil on EAE clinical severity clearly show a dose-related effect (Fig.  3) . Both the 750 and 1000 mg/kg dose groups had marked reductions in mean severity score throughout the clinical disease phase. Additionally, the 1000 mg/kg group had a faster recovery rate than the 750 mg/kg group and in comparison with the untreated EAE group at the height of clinical severity (day 17) had a significantly lower (P < 0.005) severity score. There was no difference in body-weight loss between the group treated with 1000 mg linoleic acid/kg and untreated EAE (results not shown). Table 4 shows the effect of y-linolenic-acid-rich fungal oil at 200,500 and 1000 mg/kg body weight on the clinical incidence of EAE. Fungal-oil treatment at 500 mg y-linolenic acid/kg body weight protected against the development of clinical EAE, confirming the above result at the same dose level (Fig. 2) . At doses of 200 and 1000 mg y-linolenic acid/kg, the fungal oil was only effective in delaying the onset of clinical disease by 2-3 d compared with incidence data recorded for untreated EAE. Clinical severity scores showed no apparent difference in the severity of the disease in the groups treated with 200 and 1000 mg/kg to that of untreated EAE.
Doseresponse efects of fungal oil on clinical experimental autoimmune encephalomyelitis
Histopathological jindings in saflower-seed-and fungal-oil-treated Lewis rats
Animals showing severe clinical signs of EAE (control untreated group) were observed to have mononuclear cell infiltration and perivascular cuffing in spinal cord and cerebellum (Table 5 , Plate 1). In marked contrast, rats treated with fungal oil (500 mg y-linolenic acid/kg body weight) had a total absence of mononuclear infiltration ( Values were significantly different from control value, * P < 0.05, ** P < 0.005. Mean values were significantly different from control: * P < 0.05, ** P < 0.02. For details of diets, see Tables 1 and 2, and p. 103. fewer mononuclear infiltrated perivascular sites were observed in safflower-seed-oil-(1000 mg linoleic acid/kg body weight) treated animals (Table 5) .
linolenic-acid-rich fungal (Mucor javanicus) oil in Lewis rats
Lymphocyte stimulation indices 4 dafter oil treatments
At day 4, the spleen lymphoproliferative responses of safflower-seed-oil-treated rats, at Con A concentrations of 1,2 and 4 ,ug/ml, were increased 3.4-, 3.2-and 2.6-fold respectively at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19950173 compared with untreated control rats (Fig. 4) . These increases were statistically significant at 1 ,ug/ml (P < 0.02) and 2 pg/ml (P < 0.05) but not 4 ,ug/ml. Fungal-oil-treated rats compared with corresponding controls had increased T-cell lymphoproliferative responses to Con A at 2 pg/ml (P < 0.025) and 4 ,ug/ml (P < 0-02) (Fig. 4) . In contrast to safflowerseed-oil-treated rats the mean stimulation indices for fungal-oil-treated rats at 1,2 and 3 ,ug ConA/ml were only 1.3-, 1-8-and 1-7-fold higher than the control values, indicating a greater enhancement of spleen T-cell responses by safflower-seed oil, 4 d after treatment.
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No statistically significant differences between safflower-seed-and fungal-oil stimulation indices were observed.
Lymphocyte stimulation indices 12 d after oil treatments Spleen T-lymphocyte lymphoproliferative responses to Con A after 12 d safflower-seedand fungal-oil treatment are shown in Fig. 5 . Safflower-seed-oil treatment resulted in Statistically significant increases in the 1 ,ug/ml (P < 005), 2 ,ug/ml (P < 005) and 4 ,ug/ml ( P < 0-025) Con A concentrations used in the assay. No significant differences between fungal-oil-treated animals and controls were observed. Nonetheless, the mean stimulation indices for fungal oil were of a similar magnitude in the 2 and 4 ,ug Con A/ml to that of the safflower-seed-oil treatment. However, because of a higher degree of variation they were not statistically significant.
Phenotypic characteristics of spleen lymphocytes from oil-treated rats No statistically significant changes in the cell surface determinants CD4 (W3/25) and CD8 (OX-8) were detected after 4 d safflower-seed-oil treatment (Table 6) ; there was, however, a 25 % decrease in the mean proportion of CD8+ cells. There were no statistically significant changes after 12 d safflower-seed-oil treatment in the proportions of CD4+ and CD8+ cells ( Table 6) .
Results on cells obtained from rats treated for 4 d with fungal oil are shown in Table 7 . The major shift in cell proportions after 4 d fungal-oil treatment was a decrease in the CD8+ cells by 23 % relative to controls. Proportions of CD4" and CD8+ cells obtained from rats treated for 12d with fungal oil compared with control rats had a decreased mean proportion of CD8+ cells by 17%. However, none of these changes were statistically significant. Mean values were significantly different from day 0 values, * P < 0.05, ** P < 0-01. t For details of treatment and procedures, see Tables 1 and 2 and pp. 702-704.
EPG fatty acid
Spleen phosphoglyceride fatty acids from oil-treated rats Rats given oral fungal oil had a mean increase in the proportion of dihomo-y-linolenic (20 : 3n-6) and arachidonic (20: 4n-6) acids in spleen ethanolamine phosphoglycerides at day 4 (20 : 3n-6, P < 0.005 and 20 : 4n-6, P < 0.025), day 8 (20 : 3n-6, P c 0.025 and 20 : 4n-6, P > 005), and at day 12 (20: 3n-6, P < 0.005,20: 4n-6, P < 0.025) compared with day 0 samples ( Table 8) . Rats orally administered safflower-seed oil had mean increases in the proportion of dihomo-y-linolenic acid in the spleen ethanolamine phosphoglycerides at day 4 (P < 0025), day 8 ( P > 005) and day 12 (P < 0025) compared with the corresponding baseline 712 Table 9 . EfSect of saflower (Carthamus tinctorius)-seed oil administration on spleen choline (CPG) and ethanolamine (EPG) phosphoglyceride fatty acids (g/ZOO g total fatty acids measured) in Lewis rats? day 0 samples ( Table 9) . Spleen choline phosphoglycerides from rats orally administered safflower-seed oil did not show any major changes in fatty acid composition compared with day 0 samples ( Table 9) . Animals given oral fungal oil had increases in the mean proportion of dihomo-y-linolenic acid at day 4 (P c O*Ol), day 8 (P > 0.05), and day 12 (P < 0.025) compared with day 0 samples. There were also significant decreases in the 20 : 4n-6/20 : 3n-6 ratio in fungal-oil-administered animals at day 4 (P < OaOl), day 8 ( P < 0.005) and day 12 ( P < 0.009) in the choline phosphoglycerides (Table 8) .
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DISCUSSION
This study has investigated the effects of essential-fatty-acid-rich oils on the clinical and histological aspects of rat EAE, and in healthy rats examined their effects on cellular immunological variables. Treatment of Lewis-rat EAE with n-6 fatty-acid-rich safflowerseed and fungal oils was clearly beneficial in terms of the clinical and histopathological manifestations of the disease. Linoleic-acid-rich safflower-seed-oil treatment had a dosedependent action on the clinical severity of EAE, although not abolishing it, at doses of 750 and 1000 mg linoleic acid/kg body weight. Full protection against EAE was achieved with fungal oil at a dose of 500 mg y-linolenic acid/kg body weight. At 200 and 1000 mg ylinolenic acid/kg body weight, however, fungal oil was only effective in delaying the onset of clinical disease by 2-3 d. Full clinical protection by fungal oil was associated with a marked absence of CNS mononuclear cell infiltration whilst a lower clinical severity induced by safflower-seed oil corresponded to fewer CNS mononuclear cell infiltrates. The strikingly protective effect of fungal oil at 500 mg y-linolenic acid/kg body weight is a new and important finding.
Results obtained in the present study demonstrate a dose-dependency effect of linoleicacid-rich safflower-seed oil on the clinical severity of rat EAE. Based on the partial 7-L I N 0 L E N I C ACID AND EN C E P HA LO M Y E L I TI S 713 suppression of clinical incidence, Stackpoole & Mertin (198 1) reported dose-dependent effects of a high-linoleic and low-y-linolenic-acid oil (73 g linoleic and 8 g y-linolenic acid/100 g oil) on rat EAE. Linoleic acid may only be able to exert a high suppressional effect on EAE of a low clinical severity. This might explain the differences in observations for suppression of severity observed in the present study as opposed to incidence reported by Stackpoole & Mertin (1981) whose control EAE animals did show lower clinical severity signs than those reported here. It is also possible that the small y-linolenic acid content of the oil used by Stackpoole & Mertin (1981) might be a significant factor in EAE suppression, although the present findings suggest that this would only have delayed the onset of EAE.
Mertin et al. (1984, 1985) proposed a bell-shaped doseresponse action of E-series prostaglandins and their precursors on cell-mediated immune responses. However, the ' U '
shaped incidence dose response for EAE to y-linolenic-acid-rich fungal oil observed in the present study does not appear to fit that predicted by Mertin et al. (1984, 1985) . Furthermore, suppression of guinea-pig EAE (Meade et al. 1978 ) required far less linoleic acid (125-175 mg/kg body weight) than in the rat (750-1000 mg/kg body weight), even though the guinea-pig is a much slower 'desaturator' of linoleic acid (Crawford et al. 1977) . This suggests that essential fatty acids act on cellular immunological reactions via mechanisms other than just their oxygenated eicosanoid metabolites. Both safflower-seed oil and fungal oil enhanced the splenic T-lymphoproliferative responses in healthy rats as determined ex vivo by a Con A proliferation assay, the responses being maximal after 4 d treatment with oils. In addition, safflower-seed-oil treatment at 4 and 12d exerted a greater stimulatory effect on the Con A response compared with fungal oil treatment. This may be due to a specific effect of linoleic acid or the higher administration dose. Importantly, these responses do not appear to be associated with significant changes in splenic CD8+ and CD4+ T-cell sub-sets and also indicate that the oils do not produce gross T-cell suppression. Effects of linoleic acid or linoleic-acid-rich oils on lymphocyte mitogenic responses appear to be inconsistent in the literature (Kelly & Parker, 1979; Kollmorgen et al. 1979; Young et al. 1987; Calder et al. 1992) . Important differences are, however, apparent when comparing results obtained in the present investigation with those of others. These differences include: the ex vivo nature of the present experiment rather than addition of fatty acids to cell culture medium; doses used; their routes of administration; species differences and the use of vitamin E-stripped oil by some workers. Moreover, the enhancement of the Con A response by both oils is an unexpected finding in view of the suppressive effects of the oils, at the same doses, on EAE, a T-cell mediated disease. It is possible, however, that the lympho-proliferative responses to neural-antigen(s) is specifically suppressed by the oils.
Biochemical evidence of increased proportions of membrane dihomo-y-linolenic and arachidonic acids was observed in spleen phosphoglycerides effected by both oils, but particularly by fungal oil. This metabolic response in the case of fungal oil is most likely the result of its relatively high y-linolenic acid content. The latter bypasses the rate-limiting A-6 desaturase step and is converted to dihomo-y-linolenic and arachidonic acids (Hassam et al. 1975; Phylactos et al. 1994) . More importantly, fungal oil specifically decreased the spleen arachidonic : dihomo-y-linolenic-acid ratio suggesting that the A-5 desaturase is ratelimited in its ability to desaturate dihomo-y-linolenic acid in fungal-oil-treated animals. It is therefore possible that dihomo-y-linolenic acid may be responsible for fungal oil-induced suppression of EAE The mechanism of action of the oils on EAE may be via modulation of critical Tlymphocyte surface molecules involved in antigen-specificity, self recognition, co-operative functions and/or T-cell receptor signal transduction. The precursor fatty acids dihomo-y-linolenic and arachidonic acids when converted to the eicosanoids prostaglandin El (PGE,) and PGE, respectively may also modify immune responses in EAE. Effector T-lymphocytes in Lewis rat EAE are of the CD4+ OX22+ phenotype, a CD4' sub-set known to produce high levels of interleukin-2 (IL-2) (Hayosh et al. 1989) . The CD4+ 0x22' sub-set has lymphokine characteristics of mouse CD4+ clones designated TH, (Mosmann & Coffman, 1989) . It is precisely this CD4+ sub-set that is PGE,-sensitive, PGE, inhibiting both IL-2 and interferon-y (IFN-y) production (Betz & Fox, 1991) . This could therefore be an immunoregulatory circuit whereby PGE, or PGE,, both oxygenated C20-essential fatty acids, mediate the suppression of Lewis rat EAE. Cytokines other than these mentioned above, particularly transforming growth factor p1 (TGFP,) and IL-4, may also be influenced by dihomo-y-linolenic and arachidonic acids.
In summary, our studies show that Lewis rat EAE can be partially suppressed by linoleicacid-rich safflower-seed oil whilst y-linolenic-acid-rich fungal oil, depending on dose, exerts full protection against the disease. In healthy Lewis rats oil doses found to be suppressive in EAE enhanced the splenic T-lymphoproliferative response to Con A, but did not affect the proportion of CD8+ or CD4+ cells. Biochemical studies suggest that with both oils these responses are associated with increased proportions of dihomo-y-linolenic acid in spleen phospholipids, whilst fungal oil induces a specific increase in ethanolamine phosphoglyceride arachidonic acid and a decrease in the arachidonic : dihomo-y-linolenic acid ratio in choline phosphoglycerides.
